ESR1 and breast carcinoma: Considering that STAT1 expression has been associated with improved outcome prediction in patients with breast cancer [15] and STAT1 levels were found either undetectable or very low in 45% of ERα+ breast cancer patients [14], these tumor cell lines represent a clinically relevant ERα+/PR+ mammary tumor model.